Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
Orla Fitzpatrick,1 Jarushka Naidoo1,2 1Department of Oncology, Beaumont Hospital, RCSI University of Health Sciences, Dublin, Ireland; 2Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, 21231, USACorrespondence: Jarushka NaidooBeaumont Hosp...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/01f89d883ac44a82874552e46fc7f16f |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|